Anti-Carbonic Anhydrase 9/CA9 antibody [2D3]
5
(2 Reviews)
|
(15 Publications)
Mouse Monoclonal Carbonic Anhydrase 9 antibody. Suitable for Flow Cyt, WB, IHC-P and reacts with Human samples. Cited in 15 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CA9.
View Alternative Names
G250, MN, CA9, Carbonic anhydrase 9, Carbonate dehydratase IX, Carbonic anhydrase IX, Membrane antigen MN, P54/58N, Renal cell carcinoma-associated antigen G250, pMW1, CA-IX, CAIX, RCC-associated antigen G250
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Carbonic Anhydrase 9/CA9 antibody [2D3] (AB107257)
Immunohistochemical analysis of paraffin-embedded lung tissues (left) and colonic tissues (right) using 1/200 ab107257 with DAB staining.
- Flow Cyt
Unknown
Flow Cytometry - Anti-Carbonic Anhydrase 9/CA9 antibody [2D3] (AB107257)
Flow cytometric analysis of NTERA-2 cells using Carbonic Anhydrase 9/CA9 mouse ab107257 in green and negative control in purple.
- WB
Unknown
Western blot - Anti-Carbonic Anhydrase 9/CA9 antibody [2D3] (AB107257)
All lanes:
Western blot - Anti-Carbonic Anhydrase 9/CA9 antibody [2D3] (ab107257) at 1/500 dilution
Lane 1:
Hela Cell lysate
Lane 2:
A549 Cell Lysate
Predicted band size: 49 kDa
false
Related conjugates and formulations (1)
-
Anti-Hepatitis B Virus pre S2 Antigen antibody [2D3]
Reactivity data
Product details
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (15)
Recent publications for all applications. Explore the full list and refine your search
Integrative biology : quantitative biosciences from nano to macro 15: PubMed37874173
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer letters 571:216338 PubMed37549770
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC biology 21:98 PubMed37106386
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in oncology 13:1116648 PubMed36816933
2023
Applications
Unspecified application
Species
Unspecified reactive species
ACS omega 8:5787-5807 PubMed36816648
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer letters 528:76-84 PubMed34973392
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of enzyme inhibition and medicinal chemistry 36:954-963 PubMed33947294
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology reports 43:817-826 PubMed32020234
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 29:4086-4098.e6 PubMed31851935
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental dermatology 28:976-980 PubMed31125456
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com